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November	 2015	who	were	not	 eligible	 to	 be	 randomised	 to	 the	
interventional	 trial	 because	 either	 their	 Fibtem	 A5	 remained	 >15	 mm	 or	 bleeding	 stopped.	 One	






the	 enrolment	 characteristics	 of	 the	 women	 who	 were	 randomised	 are	 shown	 for	 comparison.	
Women	in	the	observational	group	had	smaller	bleeds	at	study	entry	and,	as	a	direct	consequence	of	
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Demographics	 	 	 	
Age	at	recruitment	(years)	Mean	(range)	 31.87	(18-46)	 32.1	(20-48)	 0.8	
Body	mass	index	at	booking	Mean	(sd)	 27.43	(6.29)	 25.91	(5.00)	 0.04	
Missing	 3	 1	 	
Previous	caesarean	section	N	(%)		 123	(20.3)	 18	(32.7)	 0.03	
Pre-eclampsia	during	this	pregnancy	N	(%)	 30	(5.0)	 8	(14.5)	 0.003	
Past	history	of	postpartum	haemorrhage	N	(%)	 59	(9.8)	 11	(20.0)	 0.02	
Delivery		 	 	 	
Onset	of	labour	N	(%)	 	 	 	
Spontaneous	 214	(35.4)	 18	(32.7)	 	
Induced	 224	(37.0)	 11	(20.0)	 0.004	
No	labour	 167	(27.6)	 26	(47.3)	 	
Multiple	gestation	N	(%)	 	 	 	
Singleton	 564	(93.2)	 49	(89.1)	 0.3	




Uterine	atony	 373	(61.7)	 39	(70.9)	 NA	
Surgical	bleeding	 207	(34.2)	 19	(34.5)	 	
Trauma	 174	(28.8)	 10	(18.2)	 	
Retained	placenta	 70	(11.6)	 6	(10.9)	 	
Placental	abruption	 23	(3.8)	 5	(9.1)	 	
Placenta	praevia		 38	(6.3)	 3	(5.5)	 	
Undiagnosed	placenta	accrete	 2	(0.3)	 1	(1.8)	 	
Mode	of	delivery
†
N	(%)	 	 	 	
Spontaneous	vaginal	 167	(27.6)	 13	(23.6)	 	
Instrumental	vaginal	 140	(23.1)	 7	(12.7)	 0.2	
Elective	caesarean	section	 132	(21.8)	 16	(29.1)	 	
Non-elective	caesarean	section	 166	(27.4)	 19	(34.5)	 	
	*	women	may	have	had	more	than	one	cause	of	bleeding,	†for	multiple	pregnancies,	the	most	invasive	mode	is	
taken,	NA	is	not	available	because	many	women	had	multiple	causes	of	bleeding	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Estimated	blood	loss	at	study	entry	(mL)									
Median	(25th	to	75th	centiles)	
1200	
(1000	to	1500)	
1450	
(1200	to	1800)	
	
0.002	
Haemostatic	tests	at	study	entry		
Median	(25th	to	75th	centiles)	
Haemoglobin	(g/L)	
	
	
107	(97	to	116)	
	
	
95	(86	to	108)	
	
	
<0.001	
Missing	
Fibtem	A5	(mm)	
Missing	
Clauss	Fibrinogen	(g/L)	
Missing						
Prothrombin	time	(s)	
Missing						
Activated	partial	thromboplastin	time	(s)	
Missing	
8	
19	(17	to	22.5)	
0	
4.0	(3.4	to	4.6)	
101	
10.8	(10.3	to	11.4)	
73	
25.0	(23.2	to	27.2)	
86	
0	
12	(9	to	14)	
0	
2.7	(2.4	to	3.3)	
4	
10.9	(10.2	to	12.0)	
1	
26.0	(22.8	to	30.0)	
7	
	
<0.001	
	
<0.001	
	
0.2	
	
0.2	
Table	2.	Study	outcomes	by	cohort	
Outcome	 Observational	
cohort	
(n=605)	
Interventional	
cohort	
(n=55)	
Blood	loss	
Blood	loss	after	study	entry	
Median	(25
th
	to	75
th
	centile)	
range	
Missing	
300		
(50-545)	
0	to	3800	
	12
*
	
896		
(500	to	1400)	
0	to	3600	
Total	blood	loss		
Median	(25th	to	75th	centile)	
range	
1500		
(1300	to	2000)	
650	to	5500	
2480		
(1982.5	to	3260)	
1028	to	5300	
Total	blood	loss	>2500	mL	N	(%)	 40	(6.6)	 26	(47.3)	
Transfusion	
Red	blood	cells	
Median	(25th	to	75th	centile)	units	
Number	transfused	N	(%)	
Number	transfused	4	or	more	units	N	(%)	
	
0	(0	to	0)	
141	(23.3)	
11	(1.8)	
	
2	(0	to	4)	
35	(63.6)	
16	(29.1)	
Fresh	frozen	plasma	
Median	(25th	to	75th	centile)	units	
Number	transfused	N	(%)	
	
0	(0	to	0	
12	(2.0)	
	
0	(0	to	1)	
14	(25.5)	
Cryoprecipitate		
Median	(25th	to	75th	centile)	units	
Number	transfused	N	(%)	
	
0	(0	to	0	
2	(0.3)	
	
0	(0	to	0)	
2	(3.6)	
Platelets	
Median	(25th	to	75th	centile)	units	
Number	transfused	N	(%)	
	
0	(0	to	0)	
1	(0.2)	
	
0	(0	to	0)	
7	(12.7)	
Cell	salvage	
Median	(25th	to	75th	centile)	
Number	transfused	N	(%)	
	
0	(0	to	0)	
27	(4.5)	
	
0	(0	to	0)	
3	(5.5)	
Obstetric	interventions	to	control	bleeding	
Number	of	uterotonic	doses	used		
Median	(25th	to	75th	centile)	
range		
	
2	(2	to	4)		
1	to	9	
	
3	(5	to	6)		
2	to	8	
Number	of	invasive	procedures	
Median	(25th	to	75th	centile)	
range		
	
Women	requiring	no	invasive	procedure	N	(%)	
Women	requiring	one	invasive	procedure	N	(%)	
Women	requiring	two	invasive	procedures	N	(%)	
Women	requiring	three	invasive	procedures	N	(%)	
Women	requiring	four	invasive	procedures	N	(%)	
Women	requiring	five	invasive	procedures	N	(%)	
	
Type	of	invasive	procedure†	
Hysterectomy	N	(%)	
Intra-uterine	balloon	catheter	N	(%)	
Uterine	compression	sutures	N	(%)	
Manual	removal	of	placenta	N	(%)	
Perineal	repair	N	(%)	
Vaginal	pack	N	(%)	
Examination	under	anaesthetic	N	(%)	
Laparotomy	N	(%)	
	
0	(0	to	1)	
0	to	5	
	
322	(53.2)	
173	(28.6)	
80	(13.2)	
21	(3.5)	
7	(1.2)	
2	(0.3)	
	
1	(0.2)	
45	(7.4)	
9	(1.5)	
57	(9.4)	
154	(25.5)	
80	(13.2)	
62	(10.2)	
2	(0.3)	
7	(1.2)	
	
1	(0	to	2)	
0	to	4	
	
22	(40.0)	
10	(18.2)	
11	(20.0)	
11	(20.0)	
1	(1.8)	
0	(0)	
	
(0)	
15	(27.3)	
2	(3.6)	
4	(7.2)	
11	(20)	
15	(27.3)	
18	(32.7)	
4	(7.3)	
0	(0)	
Outcome	 Observational	
cohort	
(n=605)	
Interventional	
cohort	
(n=55)	
Bimanual	compression	N	(%)	
Other	not	stated	N	(%)	
Interventional	radiology	N	(%)	
Uterine	artery	ligation	N	(%)	
14	(2.3)	
0	(0)	
0	(0)	
0	(0)	
0	(0)	
0	(0)	
Use	of	tranexamic	acid	
												Number	treated	N	(%)	
	
182	(30.1)	
	
55	(100%)	
Hospital	stay	and	Level	2	and	3	care	
Level	3	care	N	(%)	
Length	of	stay	of	women	admitted	to	level	3	care	(hrs)		
											Median	(25
th
	to	75
th
	centile)		
10	(1.7)	
	
21	(9.25	to	25.25)	
4	(7.3)	
	
2,	4,	18,	168
‡
.	
Level	2	care	N	(%)	
Length	of	stay	of	women	admitted	to	level	2	care	(hrs)		
											Median	(25
th
	to	75
th
	centile)	
																518	(85.6)							
	
10	(6	to18)	
51	(94)		
	
17	(10	to	26)	
Length	of	hospital	stay	(days)		
										Median	(25
th
	to	75
th
	centile)	
	
2	(2	to	4)	
	
3	(2	to	4)	
*Total	blood	loss	was	reported	to	be	less	than	blood	loss	at	study	entry	and	so	cases	were	excluded	
from	this	analysis,	†women	may	have	had	more	than	one	invasive	procedure,	
‡	
number	of	hours	for	
each	woman	is	given	due	to	low	number	of	cases.		
	
	
	
	
	
	
	
	
	
	
	
	
	
	
